Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Jensen Karsten Gjessing |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole / Jensen Karsten Gjessing en Journal of the American Academy of Child & Adolescent Psychiatry, Año 2019 - Vol. 58 - No.11 (Noviembre)
[artículo]
Título : Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole : 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial Tipo de documento: texto impreso Autores: Jensen Karsten Gjessing, Autor Fecha de publicación: 2019 Artículo en la página: pp. 1062-1078 Idioma : Inglés (eng) Palabras clave: Primer episodio de psicosis, Glucosa, Lípidos, Antipsicóticos, Predictores Resumen: To investigate cardiometabolic effects and their predictors in youths with first-episode psychosis (FEP) treated with quetiapine-extended release (ER) versus aripiprazole. Link: ./index.php?lvl=notice_display&id=21303
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2019 - Vol. 58 - No.11 (Noviembre) . - pp. 1062-1078[artículo] Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole : 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial [texto impreso] / Jensen Karsten Gjessing, Autor . - 2019 . - pp. 1062-1078.
Idioma : Inglés (eng)
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2019 - Vol. 58 - No.11 (Noviembre) . - pp. 1062-1078
Palabras clave: Primer episodio de psicosis, Glucosa, Lípidos, Antipsicóticos, Predictores Resumen: To investigate cardiometabolic effects and their predictors in youths with first-episode psychosis (FEP) treated with quetiapine-extended release (ER) versus aripiprazole. Link: ./index.php?lvl=notice_display&id=21303